Skip to main content

Table 1 Cases of previously reported low-grade papillary Schneiderian carcinoma

From: Low-grade papillary Schneiderian carcinoma with TP53 mutation: a case report and review of the literature

No

Age

Sex

Initial symptoms

Original diagnosis

Involved site

Local recurrence

Nodal metastasis

Distant metastasis

Adjunctive treatment

Follow-up

p53

Ki67

HPV

EGFR, KRAS

DEK-AFF2

Reference

1

47

F

Nasal obstruction, polyps

Fungiform Schneiderian papilloma

ES, NC, MS, FS, cheek, OB

 > 10 times (18 years)

Yes

No

CT, RT

18 years, DOD

50%

5%

-

WT

exon7-exon4

[1, 7, 8]

2

42

F

Nasal obstruction, rhinorrhea

Oncocytic papilloma

NC, MS, ES

Once (3 years)

No

No

RT

21 months, NED

50%

10%

-

NA

NA

[2]

3

65

F

Nasal obstruction

Schneiderian papilloma

NC, MS, ME, ET

Once (1 year)

No

No

RT

3 months, NED

NA

NA

NA

NA

NA

[3]

4

56

F

Nasal discharge, facial pain

Transitional proliferation with inverted growth

MS, ES, NC, PF, OB, IF

Once (1 year)

No

No

No

 > 12 months, NED

Positive

 < 10%

-

NA

NA

[4]

5

68

M

Nasal obstruction

Low-grade papillary Schneiderian carcinoma

NC

No

No

No

No

16 months, NED

50%

2–50%

-

WT

NA

[5]

6

53

F

Nasal obstruction, loss of smell, headache

Sinonasal papilloma

NC, NP, ME, ET

Four times

No

No

RT

48 months, AWD

20%

5%

-

WT

NA

[6]

7

64

F

Nasal obstruction, epistaxis, loss of smell

Inverted papilloma

NC, FS, MS, ES, SS, IF, PF, ME, NP

Four times

No

No

No

7 months, DOD

10%

5%

-

WT

NA

[6]

8

18

F

Nasal obstruction, epistaxis

Papilloma

NC, ES, MS, ET, ME, NP

Nine times

Yes

lung

CT, RT

13 months, AWD

20%

5%

-

WT

NA

[6]

9

53

F

Nasal obstruction, epistaxis, epiphora tinnitus, aural fullness

Papilloma

NC, SS, SB, ET, ME, CS, NP

Twice

Yes

No

RT

18 months, AWD

30%

10%

-

WT

exon7-exon5

[6, 8]

10

51

F

Nasal obstruction, purulent nasal discharge, epistaxis

Exophytic papilloma

NC

Twice

No

No

RT

30 months, NED

10%

5%

-

WT

exon7-exon5

[6, 8]

11

NA

NA

(from No. 11 to 14) Neurological symptoms (sensory or auditory neuropathies), facial swelling, nasal obstruction and drainage

(from No. 11 to 14) Inverted papilloma, atypical squamous proliferation with papillary features, low-grade nonkeratinizing SCC, SCC in situ arising in an inverted papilloma

NC

No

No

No

CT, RT

NED

(from No. 11 to 14) average 43% (15–70%)

(from No. 11 to 14) average 27% (5–50%)

-

WT

NA

[7]

12

NA

NA

MS

No

No

No

CT, RT

NED

-

WT

NA

[7]

13

NA

NA

Mastoid air cells, ME

No

No

No

No

NED

-

WT

NA

[7]

14

NA

NA

NC

Once (10 months)

No

No

No

15 months, AWD

-

WT

NA

[7]

15

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

-

WT

 + 

[8]

16

64

F

NA

LGPSC

NC, ES

NA

No

No

NA

NA

NA

NA

-

NA

 + 

[9]

17

76

F

Asymptomatic (detected by PET)

Inverted papilloma or LGPSC

NP

No

Yes

No

RT

13 months, DOA

NA

15%

-

NA

NA

[10]

18

69

M

Nasal obstruction, cheek swelling, purulent rhinorrhea

LGPSC

MN, ES, NC, OB, Cheek

Not resectable

No

No

CT, RT

8 months, AWD

100%

90%

-

WT

-

This case

  1. p53 and Ki67 are scores at the primary tumor of initial surgery/biopsy. HPV was tested by PCR, in situ hybridization, or p16 immunohistochemistry
  2. AWD Alive with disease, CIS Carcinoma in situ, CT Chemotherapy, CS cavernous sinus, DOA Died of another disease, DOD Died of disease, ES Ethmoid sinus, ET Eustachian tube, F Female, FS Frontal sinus, IF Infratemporal fossa, M Male, ME Middle ear, MS Maxillary sinus, NA not available, NC Nasal cavity, NED No evidence of disease, NP Nasopharynx, OB Orbit, PET Positron emission tomography, PF Pterygopalatine fossa, RT Radiation therapy, SB Skull base, SCC Squamous cell carcinoma, SS Sphenoid sinus, WT Wild type